Patent No. 603182 Disclosed is a humanized antibody capable of binding to CXCR4, wherein CDR-H1 is GFTFTDNY, CDR-H2 is IRNKANGYTT, CDR-H3 is ARDVGSNYFDY, CDR-L1 is QSLFNSRTRKNY, CDR-L2 is WAS and CDR-L3 is MQSFNLRT.
Humanized anti cxcr4 antibodies for the treatment of cancer